The Global Secondary Hyperoxaluria Drug Market is projected to register at a CAGR of 67% during the forecast period of 2022 to 2028. A multifactorial disease that affects other organs and tissues due to absorption of high oxalate concentrations due to intestinal problems is known as secondary hyperoxoaciduria or, in its extreme stages, enteric acid […]
